ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 751 out of 2888

$464K Total Retail Price of All Prescriptions

Rank: 923 out of 2888

481 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 7,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 322 284 S3 1 4
SIMVASTATIN 314 301 2 2
AMLODIPINE BESYLATE 258 228 3 5
FUROSEMIDE 248 217 4 6
LEVOTHYROXINE SODIUM 244 219 5 1
POTASSIUM CHLORIDE 219 171 6 14
ATENOLOL 215 193 7 25
LISINOPRIL 202 181 8 3
METFORMIN HCL 199 145 9 8
SERTRALINE HCL 152 145 10 27
METOPROLOL TARTRATE 152 152 10 10
METOPROLOL SUCCINATE 146 113 12 11
OMEPRAZOLE 145 144 13 7
WARFARIN SODIUM 122 110 14 22
ATORVASTATIN CALCIUM 121 98 15 9
GABAPENTIN 115 106 16 13
AMLODIPINE BESYLATE-BENAZEPRIL 114 91 17 67
HYDROCHLOROTHIAZIDE 108 105 18 15
ALLOPURINOL 107 99 19 37
DIGOXIN 98 98 20 55
TRIAMTERENE-HCTZ 98 85 20 63
CLOPIDOGREL 93 87 22 30
NEXIUM 91 56 23 19
PRAVASTATIN SODIUM 86 86 24 12
METFORMIN HCL ER 82 70 25 53
CELEBREX 81 81 26 89
AZITHROMYCIN 79 68 27 38
LOSARTAN POTASSIUM 77 77 28 18
MELOXICAM 77 67 28 31
CARVEDILOL 72 67 30 21
PLAVIX 71 67 31 40
LOVASTATIN 69 54 32 41
QUINAPRIL HCL 68 56 33 179
PANTOPRAZOLE SODIUM 67 46 34 33
LOSARTAN-HYDROCHLOROTHIAZIDE 64 53 35 46
QUETIAPINE FUMARATE 63 54 36 66
VERAPAMIL ER 57 52 37 104
PREDNISONE 56 53 38 42
CITALOPRAM HBR 56 54 38 24
LANTUS 55 22 40 45
BISOPROLOL-HYDROCHLOROTHIAZIDE 54 54 41 193
VYTORIN 54 54 41 155
ZOLPIDEM TARTRATE 53 37 43 17
TORSEMIDE 53 53 43 158
DIOVAN 52 49 45 35
TAMSULOSIN HCL 52 52 45 29
ENALAPRIL MALEATE 50 50 47 49
SPIRIVA 50 41 47 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.